Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Synergistic T cell signaling by 41BB and CD28 is optimally achieved by ...
CD3 x BCMA BISPECIFICS
Figure 3 from A PSMA-Targeting CD3 Bispecific Antibody Induces ...
A Review of T Cell Markers, CD3 Antigens and Antibodies - Creative ...
Unlocking the Power of CD3 × B Cell Bispecific Antibodies with ...
CD28 and 41BB Costimulation Enhances the Effector Function of CD19 ...
Use of bispecific antigen-binding molecules that bind muc16 and cd3 in ...
CD3 Proteins – KACTUS
CD28 and 41BB Costimulatory Domains Alone or in Combination ...
Intratumoral Activation of 41BB Costimulatory Signals Enhances CD8 T ...
Eight samples were stimulated with 4-1BB and/or CD3 antibodies during ...
4-1BB agonism that only works on site
免疫激活型抗体药物作用机制研究获进展_4-1BB
Frontiers | 4-1BB: A promising target for cancer immunotherapy
a The involvement of native CD28 and 4-1BB costimulation in T cell ...
Frontiers | Boosting Antitumor Response by Costimulatory Strategies ...
Frontiers | High specificity of engineered T cells with third ...
Gal-9 colocalizes with 4-1BB. (a) Confocal analysis of 4-1BB (red) and ...
T细胞共刺激靶标：4-1BB - 知乎
Frontiers | Targeting 4-1BB for tumor immunotherapy from bench to bedside
Tumor-Targeted Therapy Using a Fibroblast Activation Protein-4-1BB ...
HBM7008-HBM Holdings
Frontiers | Agonism of 4-1BB for immune therapy: a perspective on ...
Mechanistic model of 4-1BB agonist antibody-mediated hepatotoxicity ...
勃林格殷格翰小细胞肺癌新药DLL3/CD3双抗II期临床试验在中国获批-美通社PR-Newswire
CD40- and 41BB-specific antibody fusion proteins with PDL1 blockade ...
4-1BB signaling activates the b-catenin/TCF1 pathway in CD8 + T cells ...
惠和生物首个三抗药物获FDA批准进入临床，CD3/CD28共刺激信号三抗备受关注新闻中心
Design of a bispecific tumor-targeted 4-1BB ligand (TA-4-1BBL), which ...
Human Cord Blood CD3+ T Cells, Pure and Viable | HumanCellsBio.com ...
Twists and turns to translating 4-1BB cancer immunotherapy | Science ...
CD40/PDL1-and 41BB/PDL1-bispecific antibody fusion proteins block ...
Binding of Ig-4-1BBL to cells expressing 4-1BB. CD3/CD28-activated T ...
Selected signalling proteins recruited to the T‐cell receptor–CD3 ...
Bispecific Antibodies: A Smart Arsenal for Cancer Immunotherapies
Frontiers | The 41BB-agonist potentiates the therapeutic efficacy of a ...
An optimized IgG-based B7-H3xCD3 bispecific antibody for treatment of ...
Combined DLL3-targeted bispecific antibody with PD-1 inhibition is ...
Novel anti-4-1BB×PD-L1 bispecific antibody augments anti-tumor immunity ...
(PDF) CLDN18.2 and 4-1BB bispecific antibody givastomig exerts ...
Tumor-targeted 4-1BB agonists for combination with T cell bispecific ...
Biocytogen's DLL3×CD3×4-1BB TriAb: A New Path for TCE Therapies ...
4-1BB（CD137）：T细胞共同刺激又一重要靶标|细胞|小鼠|免疫_新浪新闻
[InvivoGen] T cell의 CD3과 CD28을 동시에 결합하는 Bispecific antibody CD3-CD28 ...
Third-generation CD28/4-1BB chimeric antigen receptor T cells for ...
AACR 2025: The trispecific T cell engager platform enhances T cell ...
TCR-independent CD137 (4-1BB) signaling promotes CD8+-exhausted T cell ...
4-1BB/CD137/TNFRSF9 (D2Z4Y) Rabbit Monoclonal Antibody (PE Conjugate ...
CD3单克隆抗体：突破性疗法的又一次“浴火重生”_细胞_异源_信号
Characterization of anti-4-1BB antibody (HZ-L-Yr-16-Fc). Binding ...
Functional characterization of a bi-specific PSMA-4-1BB aptamer ...
Bispecific Antibodies Killer Cells at Jamie Stonehouse blog
4-1BB expression in tissues, cell lines and T cells. (A) Organization ...
The PD-L1/4-1BB Bispecific Antibody–Anticalin Fusion Protein PRS-344 ...
DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T ...
JCI - 4-1BB stimulation with concomitant inactivation of adenosine A2B ...
Frontiers | 4-1BB Signaling Boosts the Anti-Tumor Activity of CD28 ...
4-1BB（CD137）：T细胞共同刺激又一重要靶标 - 知乎
T-cell activation | British Society for Immunology
Activation and toxicity profile of human anti-4-1BB Abs. a Human PBMC ...
41BB-based and CD28-based CD123-redirected T-cells ablate human normal ...
(PDF) 4-1BB: A promising target for cancer immunotherapy
Bispecific T-Cell Redirection versus Chimeric Antigen Receptor (CAR)-T ...
肿瘤免疫靶点 | T细胞共刺激分子4-1BB - 知乎
DLL3/CD3 bispecific antibody: mechanism of action - YouTube
Pipeline
Full article: The emerging landscape of novel 4-1BB (CD137) agonistic ...
(PDF) 4-1BB Signaling Activates the T Cell Factor 1 Effector/β-Catenin ...
Anti-4-1BB mAb treatment induces marked expansion of CD11c + CD8 ...
Anti–4-1BB mAbs costimulate anti-CD3–induced T cell proliferation ...
Expression of 4-1BB is upregulated on anti-Her2 CAR T cells following ...
4BL cells upregulate TNFR2 in CD8 + T cells via the 4-1BB/4-1BBL axis ...
Effects of ICT treatment on the immune microenvironment a, Fraction of ...
Whole-Body Physiologically Based Pharmacokinetic Modeling Framework for ...
CD19scFv-CD22scFv-TM-4-1BB-CD3z-T2A-RQR8 - PM-CAR1050 - Products | ProMab
Frontiers | Targeting CD137 (4-1BB) towards improved safety and ...
CD antigens related to signaling pathways
Characterization of anti-4-1BB trimerbodies. a Sensorgrams (black ...
4–1BB signal stimulates the activation, expansion, and effector ...
JCI - A conserved intratumoral regulatory T cell signature identifies 4 ...
Expression patterns of 4-1BB and 4-1BBL on PBMC of the patients with ...
相同信号、不同命运，CD28 CAR-T和4-1BB CAR-T的差异根源 - 知乎
Positions, identities, and expression of 4-1BB, DAP10, and CD3ζ ...
百利天恒：PD-L1/4-1BB/CD3/CD19四抗治疗自免适应症获批IND_细胞_创新_药物
Defective 4-1BB activity in T cells and DCs from Gal-9−/− mice. (a ...
Preclinical specificity & activity of a fully human 41BB-expressing ...
Frontiers | CD3+CD4-CD8- (Double-Negative) T Cells in Inflammation ...
【AACR 2025】上细前沿突破四 | TCE核心平台：基于抗CD3与肿瘤特异性靶点的纳米抗体库为精准免疫治疗提供核心工具
Parallel Comparison of 4-1BB or CD28 Co-stimulated CD19-Targeted CAR-T ...
Antibodies to Costimulatory Receptor 4-1BB Enhance Anti-tumor Immunity ...
| Distinct CyTOF Profile of NKG2D CAR T cells after stimulation with ...
4-1BB signaling enhances the proliferation of CD8 + T cells and their ...
细胞免疫研究的核心通路——T cell receptor signaling pathway（下）_调节_位点_信号
全新免疫检查点TIGIT全称具有Ig和ITIM结构域的T细胞免疫受体(TIGIT抗体),十款PD1新药TIGIT单抗迎来新希望_全球肿瘤医生网
4-1BB immunotherapy: advances and hurdles - PMC
Redirecting T cells to glypican-3 with 28.41BB.ζ and 28.ζ-41BBL CARs ...
4-1BB signaling activates glucose and fatty acid metabolism to enhance ...
A heightened and sustained CD4 + T cell proliferative response of 4-1BB ...
